Effect of Erythropoietin in Refractory Autoimmune Encephalitis Patients
Status:
Withdrawn
Trial end date:
2018-02-06
Target enrollment:
Participant gender:
Summary
This study evaluates the efficacy of erythropoietin in refractory autoimmune encephalitis.
Ten patients will receive 100 IU/kg of erythropoietin 3 times a week for 12 weeks.